BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced a conference call and webcast scheduled for October 30, 2024, at 8:00 a.m. CDT to discuss its first quarter fiscal 2025 financial results. Interested parties can access the call via phone or webcast. The dial-in numbers are 1-877-407-9208 for domestic callers and 1-201-493-6784 for international callers, with the Conference ID 13749405. A webcast link is also provided.

For those unable to join the live call, a recorded rebroadcast will be available from 11:00 a.m. CDT on October 30, 2024, until 11:00 p.m. CST on November 30, 2024. The replay can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and using the same Conference ID.

MINNEAPOLIS, Oct. 10, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, October 30, 2024, at 8:00 a.m. CDT to review its first quarter fiscal 2025 financial results.

Access to the discussion may be obtained as follows:

Time:	8:00 a.m. CDT
Date:	October 30, 2024
Dial-in:	1-877-407-9208 or 1-201-493-6784 (for international callers)
Conference ID:	13749405
Webcast:	https://investors.bio-techne.com/ir-calendar

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13749405.

The replay will be available from 11:00 a.m. CDT on Wednesday, October 30, 2024, until 11:00 p.m. CST on Saturday, November 30, 2024.

About Bio-Techne

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact:	David Clair, Vice President, Investor Relations & Corporate Development
	david.clair@bio-techne.com
	612-656-4416

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-october-30-2024-to-announce-first-quarter-fiscal-2025-financial-results-302271430.html

SOURCE Bio-Techne Corporation

FAQ

When will Bio-Techne (TECH) report its Q1 2025 financial results?

Bio-Techne (TECH) will report its first quarter fiscal 2025 financial results on October 30, 2024, during a conference call and webcast at 8:00 a.m. CDT.

How can investors access Bio-Techne's (TECH) Q1 2025 earnings call?

Investors can access Bio-Techne's (TECH) Q1 2025 earnings call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international), using Conference ID 13749405, or via webcast at the company's investor relations website.

Will there be a replay available for Bio-Techne's (TECH) Q1 2025 earnings call?

Yes, a replay of Bio-Techne's (TECH) Q1 2025 earnings call will be available from 11:00 a.m. CDT on October 30, 2024, until 11:00 p.m. CST on November 30, 2024, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) with Conference ID 13749405.